IgG subclass specificity to C1q determined by surface plasmon resonance using Protein L capture technique

Rekha Patel1, Alyssa Neill1, Hongcheng Liu1

  • 1Product Characterization, Alexion Pharmaceuticals, Inc, USA.

Recombinant monoclonal antibodies (mAbs) have become an important category of biological therapeutics. mAbs share the same structures and biological functions as endogenous IgG molecules. One function is complement-dependent cytotoxicity (CDC) initiation by binding of C1q. Traditionally, ELISA methods have been utilized to measure C1q binding. A new robust capture method was established in this study to measure the binding affinity of C1q to antibodies by surface plasmon resonance (SPR). The utility of this method was demonstrated by determination of the difference in IgG subclass specificity of C1q binding.

Related Concept Videos